Maryland Team Wins First Phase of NEI Contest to Create Human Retina

October 6, 2017: By Jon Swedien
Erin Lavik, ScD

Erin Lavik, ScD

A team from the University of Maryland, Baltimore County, beat out 12 other entries to win the first phase of a National Eye Institute (NEI) contest to create a living model of the human retina.

The NEI, part of the National Institutes of Health, announced the winner Sept. 28. The honor included a prize of $90 thousand.

The NEI’s 3-D Retina Organoid Challenge (3-D ROC) initiative seeks to design human retinas from stem cells. The submissions were evaluated based on their innovativeness and feasibility, the NEI said.

The winning concept was a proposal to build a retina by screen printing adult neural progenitor-derived retinal neurons in layers that mimic the structure of the human retina. The system is designed to be scalable, efficient, and reproducible, enabling high-throughput screening for drug testing, the NEI said. Erin Lavik, ScD, led the winning team.

The NEI plans to launch a second phase of the contest this fall and to award a combined total of $1 million to teams that demonstrate the functionality of a retina organoid prototype. Further details on the challenge will be provided in an official announcement, NEI said.

NEI also awarded five teams with an honorable mention. They were led by:

–Rebecca Carrier, PhD, Northeastern University, Boston;

–David Gamm, MD, PhD, University of Wisconsin, Madison;

–Wei Liu, PhD, Albert Einstein College of Medicine, Bronx, New York;

–Daniel Pelaez, PhD, University of Miami, Florida;

–Katja Schenke-Layland, PhD, Fraunhofer Institute for Interfacial Engineering and Biotechnology, Stuttgart, Germany.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

Eylea Gains Approval in China for DME-Related Visual Impairment

Second Trial for Ophthalmic Industry Leader James Mazzo Ends in Hung Jury, Mistrial

Melgen Receives 17-Year Sentence for Medicare Fraud

NIH’s National Eye Institute Solicits Next-Generation Retina Organoids in $1 Million Prize Competition

Taiwan Liposome Company Registers for $50 Million IPO in US

US FDA Approves Icon Bioscience’s DEXYCU for Post-Cataract Surgery Inflammation

FDA’s Gottlieb Appears to Soften Stance on Compounding for Office Use

Genentech’s RG7716 Outperformed Ranibizumab in Phase II Study in Diabetic Macular Edema

Santen Reports Promising Data in Phase I/II Study in Refractory Wet AMD

Q Biomed Signs Agreement with Washington University for Novel Biomarker for Monitoring Glaucoma

pSivida’s Durasert for Posterior Segment Uveitis Yields Positive 12-Month Results in Second Phase III Study

Foundation Fighting Blindness Provides $7.5 Million to Help Develop ProQR’s Candidate for Usher Syndrome

Presbia Names Casey Lind as Chief Operating Officer, Magda Michna, MD, PhD, as Chief Clinical Officer

Astellas Acquires Universal Cells

Pixium Vision Completes Two Successful PRIMA Implantations in Atrophic Dry AMD Patients

Omeros Loses Pass-through Status for Omidria

USC Donations Drop $100 Million after Puliafito Scandal, Report Says

Regeneron’s US Eylea Sales Increase 14 Percent in Q4-2017

Allergan’s Net Sales Climb 12 Percent in Q4-2017; Restasis Sales Grow Nearly 1 Percent

Lucentis’ US Sales Drop 11 percent in Q4-2017, Grow 1 Percent for Full 2017

Coming soon

2018 Retinal Surgical Devices Report: A Global Market Analysis for 2017 to 2023